Search by Drug Name or NDC

    NDC 68084-0447-01 Hydralazine Hydrochloride 10 mg/1 Details

    Hydralazine Hydrochloride 10 mg/1

    Hydralazine Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is HYDRALAZINE HYDROCHLORIDE.

    Product Information

    NDC 68084-0447
    Product ID 68084-447_f2f6a6a4-9f02-25f4-e053-2995a90adfc3
    Associated GPIs 36400010100305
    GCN Sequence Number 000284
    GCN Sequence Number Description hydralazine HCl TABLET 10 MG ORAL
    HIC3 A4A
    HIC3 Description ANTIHYPERTENSIVES, VASODILATORS
    GCN 01241
    HICL Sequence Number 000089
    HICL Sequence Number Description HYDRALAZINE HCL
    Brand/Generic Generic
    Proprietary Name Hydralazine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydralazine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name HYDRALAZINE HYDROCHLORIDE
    Labeler Name American Health Packaging
    Pharmaceutical Class Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA086242
    Listing Certified Through 2024-12-31

    Package

    NDC 68084-0447-01 (68084044701)

    NDC Package Code 68084-447-01
    Billing NDC 68084044701
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-447-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-447-11)
    Marketing Start Date 2010-09-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.03239
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description HYDRALAZINE 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis